中国临床康复
中國臨床康複
중국림상강복
CHINESE JOURNAL OF CLINICAL REHABILITATION
2004年
4期
762-763
,共2页
陈海波%曾湘豫%张文记%秦斌%郑剑晖%李淑华%王新德
陳海波%曾湘豫%張文記%秦斌%鄭劍暉%李淑華%王新德
진해파%증상예%장문기%진빈%정검휘%리숙화%왕신덕
帕金森病%统计学%一致性,结果
帕金森病%統計學%一緻性,結果
파금삼병%통계학%일치성,결과
目的:对反映帕金森病患者运动功能障碍的评分量表--帕金森病运动功能评分量(motor dysfunction rating scale for Parkinson's diseaese,MDRSPD)的一致性和敏感性的评定,体现其优越性.方法:对5个评定者之间用MDRSPD评价20例帕金森病患者的运动功能的评分结果做Kappa检验;对另20例帕金森病患者治疗前后的评分结果进行t检验.结果:该量表15个项目的Kappa检验,最低K=0.66,最高K=0.97;20例帕金森病患者治疗前后得分分别为(19.68±7.94),(16.03±7.19)分,治疗前后评分结果差异有显著性意义(t=7.13,P<0.001).结论:MDRSPD评定者之间一致性良好,且能敏感地反映出病情变化,可用于帕金森病患者的病情严重程度和治疗疗效的评定.
目的:對反映帕金森病患者運動功能障礙的評分量錶--帕金森病運動功能評分量(motor dysfunction rating scale for Parkinson's diseaese,MDRSPD)的一緻性和敏感性的評定,體現其優越性.方法:對5箇評定者之間用MDRSPD評價20例帕金森病患者的運動功能的評分結果做Kappa檢驗;對另20例帕金森病患者治療前後的評分結果進行t檢驗.結果:該量錶15箇項目的Kappa檢驗,最低K=0.66,最高K=0.97;20例帕金森病患者治療前後得分分彆為(19.68±7.94),(16.03±7.19)分,治療前後評分結果差異有顯著性意義(t=7.13,P<0.001).結論:MDRSPD評定者之間一緻性良好,且能敏感地反映齣病情變化,可用于帕金森病患者的病情嚴重程度和治療療效的評定.
목적:대반영파금삼병환자운동공능장애적평분량표--파금삼병운동공능평분량(motor dysfunction rating scale for Parkinson's diseaese,MDRSPD)적일치성화민감성적평정,체현기우월성.방법:대5개평정자지간용MDRSPD평개20례파금삼병환자적운동공능적평분결과주Kappa검험;대령20례파금삼병환자치료전후적평분결과진행t검험.결과:해량표15개항목적Kappa검험,최저K=0.66,최고K=0.97;20례파금삼병환자치료전후득분분별위(19.68±7.94),(16.03±7.19)분,치료전후평분결과차이유현저성의의(t=7.13,P<0.001).결론:MDRSPD평정자지간일치성량호,차능민감지반영출병정변화,가용우파금삼병환자적병정엄중정도화치료료효적평정.
AIM: To analysis of the agreement and sensibility of motor dysfunction rating scale for Parkinson' s disease(MDRSPD) as well as the advantages of this scale.METHODS: Kappa test was introduced in the evaluation of the results from 5 raters for assessing the movement functions of 20 Parkinson' s disease (PD)patients. Student' s t test was introduced in the evaluation of the results before and after the treatment of 20 PD patients.RESULTS: The 15 items of the employed scale were tested by Kappa test with the Kmin = 0. 66 and Kmax = 0.97, and the scores of the 20 patients before and after treatment were 19. 68 + 7.94 and 16.03 + 7.19 respectively,which had a significant difference( t = 7.13, P < 0. 001 ).CONCLUSION: MDRSPD agreement among different assessors is good and can sensitively reflect the disease variation, which can be used for evaluating disease severity as well as the treatment effectiveness in PD patients.